Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MTX-001 for the Treatment of Non-Healing Venous Stasis Ulcers
NCT04647240Phase 2Recruiting
- Sponsor
- Merakris Therapeutics
- Start
- Feb 2022
- Primary completion
- Mar 2027
- Modality
- Lipid-based Nanoparticles
- Countries
- 1
01
Overview
A Phase 2 trial of Dermacyte Liquid in venous stasis ulcer, sponsored by Merakris Therapeutics. Started Feb 2022; status: recruiting.
02
Drugs
Dermacyte Liquid
03
Conditions
venous stasis ulcer
Beyond the preview
Go deeper on NCT04647240.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04647240.